GO:0004753 saccharopine dehydrogenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004753 saccharopine dehydrogenase activity catalyzes the cleavage of saccharopine to release lysine or glutamate with concomitant reduction of an electron acceptor.
• The enzyme is a key component of the saccharopine pathway for lysine catabolism, operating in both bifunctional and monofunctional forms in mammals and plants.
• In Arabidopsis, the bifunctional lysine-ketoglutarate reductase/saccharopine dehydrogenase enzyme is regulated by interaction between its two domains.
• The catabolic function of the alpha-aminoadipic acid pathway in plants is associated with unidirectional activity of lysine-oxoglutarate reductase but not saccharopine dehydrogenase.
• Saccharopine dehydrogenase activity is linked to human diseases such as L-2-hydroxyglutaric aciduria and other saccharopine pathway-related disorders.
• Research tools including CRISPR knockout, point mutation, and overexpression models are essential for dissecting the role of saccharopine dehydrogenase in metabolism and disease.
Description
Saccharopine dehydrogenase activity (GO:0004753) is a molecular function that catalyzes the cleavage of N6-(L-1,3-dicarboxypropyl)-L-lysine, also known as saccharopine, to release an amino acid (lysine or glutamate) with the concomitant reduction of an electron acceptor. This enzymatic activity is a critical step in the saccharopine pathway, the major route for lysine catabolism in mammals and plants. The reaction is reversible and can function in either the forward direction for lysine degradation or the reverse direction for lysine biosynthesis, depending on the organism and metabolic context. Researchers study this activity to understand fundamental amino acid metabolism, its regulation, and its implications in metabolic disorders and neurological diseases. The enzyme exists in both bifunctional and monofunctional forms, with the bifunctional form containing both lysine-ketoglutarate reductase and saccharopine dehydrogenase activities on a single polypeptide chain. In plants, the bifunctional enzyme is regulated by functional interaction between its two domains, highlighting the complexity of its control. This article provides a comprehensive overview of the mechanism, genes, research methods, and disease relevance of saccharopine dehydrogenase activity, based on authoritative QuickGO data and verified PubMed literature.
saccharopine dehydrogenase activity At A Glance
| GO ID | GO:0004753 |
|---|---|
| GO term | saccharopine dehydrogenase activity |
| Ontology | molecular_function |
| Synonym | lysine-2-oxoglutarate reductase activity; lysine-ketoglutarate reductase activity |
| Major function | Catalyzes the cleavage of saccharopine to release lysine or glutamate with reduction of an electron acceptor |
| EC number | 1.5.1.7 (saccharopine dehydrogenase, NAD+, L-lysine-forming); 1.5.1.8 (saccharopine dehydrogenase, NADP+, L-glutamate-forming) |
| Pathway | Lysine degradation via saccharopine pathway; alpha-aminoadipic acid pathway |
| Subcellular location | Mitochondrial matrix (in mammals); cytosol and plastids (in plants) |
| Cofactor | NAD+ or NADP+ as electron acceptor |
What Is GO:0004753?
Saccharopine dehydrogenase activity (GO:0004753) is defined by the Gene Ontology as the catalysis of the cleavage of N6-(L-1,3-dicarboxypropyl)-L-lysine (saccharopine) to release an amino acid (lysine or glutamate), with the concomitant reduction of an electron acceptor. This activity is synonymous with lysine-2-oxoglutarate reductase activity and lysine-ketoglutarate reductase activity. In essence, it is an oxidoreductase that breaks down saccharopine, a key intermediate in lysine metabolism, while reducing a cofactor such as NAD(P)+.
Why Is saccharopine dehydrogenase activity Important in Cell Biology?
Saccharopine dehydrogenase activity is essential for lysine catabolism, a fundamental metabolic process that regulates lysine levels and produces key metabolites such as alpha-aminoadipic acid and glutamate. Dysregulation of this activity has been linked to metabolic disorders including L-2-hydroxyglutaric aciduria and other saccharopine pathway-related diseases. In plants, the enzyme is critical for seed development and nitrogen recycling, and its activity is tightly regulated by domain interactions. Understanding this activity provides insights into amino acid homeostasis, metabolic engineering, and potential therapeutic targets for neurological and metabolic diseases.
• Regulates lysine homeostasis and prevents hyperlysinemia.
• Produces glutamate, a key neurotransmitter and metabolic intermediate.
• Involved in the saccharopine pathway, a major route for lysine degradation in mammals.
• Mutations or deficiencies are associated with L-2-hydroxyglutaric aciduria and other neurometabolic disorders.
• Bifunctional enzyme in plants regulates seed lysine content and nitrogen use efficiency.
• Target for therapeutic intervention in saccharopine pathway-related diseases.
• Plays a role in the alpha-aminoadipic acid pathway in plants, affecting unidirectional flux.
• Active site thiol oxidation state modulates enzyme activity at low pH, linking redox regulation to metabolism.
• Essential for lysine catabolism in both monofunctional and bifunctional enzyme forms.
• Provides a model for studying enzyme domain interactions and metabolic channeling.
What Happens During saccharopine dehydrogenase activity?
Substrate Binding and Cleavage
In simple terms: The enzyme grabs saccharopine and breaks it apart.
Saccharopine dehydrogenase binds its substrate, N6-(L-1,3-dicarboxypropyl)-L-lysine (saccharopine), in the active site. The enzyme catalyzes the cleavage of the carbon-nitrogen bond, releasing either lysine or glutamate, depending on the direction of the reaction and the specific isoform. This step is reversible and can proceed in the forward direction for lysine degradation or the reverse direction for lysine biosynthesis.
Electron Acceptor Reduction
In simple terms: The enzyme uses a helper molecule to accept electrons during the reaction.
Concomitant with substrate cleavage, an electron acceptor such as NAD+ or NADP+ is reduced to NADH or NADPH, respectively. This redox reaction is essential for the catalytic cycle and is coupled to the oxidation of the substrate. The oxidation state of active site thiols can influence this process, particularly at low pH.
Bifunctional Enzyme Domain Interaction
In simple terms: In some organisms, two enzyme activities are joined together and talk to each other.
In plants and some mammals, saccharopine dehydrogenase activity resides on a bifunctional enzyme that also contains lysine-ketoglutarate reductase activity. The activity of this bifunctional enzyme is regulated by functional interaction between its two domains, ensuring coordinated lysine catabolism. This domain crosstalk can modulate the overall flux through the saccharopine pathway.
Unidirectional Activity in Plants
In simple terms: In plants, the enzyme often works in only one direction.
The catabolic function of the alpha-aminoadipic acid pathway in plants is associated with unidirectional activity of lysine-oxoglutarate reductase, but not saccharopine dehydrogenase, suggesting that the dehydrogenase step may be bypassed or regulated differently in plants. This unidirectional activity ensures efficient lysine degradation without futile cycling.
Regulation by pH and Redox State
In simple terms: The enzyme's activity can change with acidity and the redox environment.
The oxidation state of active site thiols determines the activity of saccharopine dehydrogenase at low pH, providing a mechanism for redox-dependent regulation. This sensitivity to pH and redox conditions may allow the enzyme to adapt to metabolic states and cellular stress.
Key Genes Involved in GO:0004753 saccharopine dehydrogenase activity
The following genes and proteins are directly involved in saccharopine dehydrogenase activity or its regulation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AASS | Bifunctional lysine-ketoglutarate reductase/saccharopine dehydrogenase in mammals | Mutations cause hyperlysinemia and neurological disorders |
| LKR/SDH | Bifunctional enzyme in Arabidopsis thaliana | Regulates lysine catabolism and seed development |
| SDH | Monofunctional saccharopine dehydrogenase in mammals | Provides alternative route for lysine degradation |
| LKR | Lysine-ketoglutarate reductase domain | Interacts with SDH domain to regulate activity |
| DHTKD1 | Dehydrogenase E1 and transketolase domain containing 1 | Associated with alpha-aminoadipic acid pathway |
| AGXT2 | Alanine-glyoxylate aminotransferase 2 | Involved in lysine metabolism and L-2-hydroxyglutaric aciduria |
| L2HGDH | L-2-hydroxyglutarate dehydrogenase | Mutations cause L-2-hydroxyglutaric aciduria |
| SLC25A1 | Mitochondrial citrate carrier | Linked to saccharopine pathway metabolite transport |
| PYCR1 | Pyrroline-5-carboxylate reductase 1 | Related to glutamate metabolism |
| GLUD1 | Glutamate dehydrogenase 1 | Connects saccharopine pathway to glutamate homeostasis |
| OAT | Ornithine aminotransferase | Involved in glutamate and arginine metabolism |
| PRODH | Proline dehydrogenase | Links to glutamate and redox balance |
| ALDH4A1 | Aldehyde dehydrogenase 4 family member A1 | Related to glutamate metabolism |
| GOT1 | Glutamic-oxaloacetic transaminase 1 | Connects to aspartate and glutamate |
| GOT2 | Glutamic-oxaloacetic transaminase 2 | Mitochondrial glutamate metabolism |
| IDH2 | Isocitrate dehydrogenase 2 | Provides NADPH for reductive steps |
| SIRT3 | Sirtuin 3 | Regulates mitochondrial redox and enzyme activity |
How Is saccharopine dehydrogenase activity Regulated?
Saccharopine dehydrogenase activity is regulated at multiple levels. In Arabidopsis, the bifunctional lysine-ketoglutarate reductase/saccharopine dehydrogenase enzyme is controlled by functional interaction between its two domains, which modulates catalytic efficiency. The oxidation state of active site thiols determines activity at low pH, linking redox regulation to enzyme function. Additionally, the catabolic function of the alpha-aminoadipic acid pathway in plants is associated with unidirectional activity of lysine-oxoglutarate reductase, but not saccharopine dehydrogenase, suggesting that the dehydrogenase step may be bypassed or differentially regulated. In mammals, both bifunctional and monofunctional lysine-degrading enzymes contribute to saccharopine pathway flux, and their expression is likely subject to metabolic and hormonal control. Therapeutic targeting of lysine alpha-ketoglutarate reductase, which is part of the bifunctional enzyme, is being explored for saccharopine pathway-related diseases.
saccharopine dehydrogenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AASS | Hyperlysinemia, neurological disorders | Aass knockout mouse |
| L2HGDH | L-2-hydroxyglutaric aciduria | L2hgdh knockout mouse |
| LKR/SDH | Plant lysine metabolism disorders | Arabidopsis lkr/sdh mutants |
| DHTKD1 | Alpha-aminoadipic aciduria | Dhtkd1 knockout mouse |
| SLC25A1 | Saccharopine pathway-related diseases | Slc25a1 knockout cell lines |
L-2-Hydroxyglutaric Aciduria
L-2-hydroxyglutaric aciduria is a neurometabolic disorder characterized by elevated L-2-hydroxyglutarate levels. A mouse model of this disorder has been developed, and it involves dysfunction in metabolite repair pathways that intersect with lysine metabolism. Saccharopine dehydrogenase activity may contribute to the metabolic imbalance observed in this disease, as the saccharopine pathway is a source of alpha-ketoglutarate and glutamate.
Saccharopine Pathway-Related Diseases
Dysregulation of the saccharopine pathway, including saccharopine dehydrogenase activity, has been linked to various diseases. Lysine alpha-ketoglutarate reductase, a related activity, is considered a therapeutic target for saccharopine pathway-related diseases, which may include hyperlysinemia, pyridoxine-dependent epilepsy, and other neurometabolic conditions. Targeting this pathway could provide new treatment options.
Hyperlysinemia and Neurological Disorders
Deficiencies in saccharopine dehydrogenase activity can lead to hyperlysinemia, as lysine catabolism is impaired. In mammals, both bifunctional and monofunctional lysine-degrading enzymes are involved, and their dysfunction can cause accumulation of lysine and saccharopine, potentially leading to neurological symptoms. Understanding the enzyme's role is crucial for diagnosing and treating these disorders.
From saccharopine dehydrogenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of saccharopine dehydrogenase activity cause hyperlysinemia? | AASS knockout mouse or cell line |
| How does the bifunctional enzyme domain interaction regulate activity? | Point mutations in LKR or SDH domains of Arabidopsis |
| Can restoring saccharopine dehydrogenase activity rescue disease phenotypes? | Knock-in of wild-type AASS in patient cells |
| What is the subcellular localization of saccharopine dehydrogenase? | Tagged knock-in of AASS with GFP |
| Does overexpression of saccharopine dehydrogenase alter lysine catabolism? | Overexpression of AASS in HEK293 cells |
| What is the role of active site thiols in catalysis? | Site-directed mutagenesis of cysteine residues |
How to Study the saccharopine dehydrogenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay | NADH production at 340 nm | Enzyme kinetics and inhibitor testing |
| CRISPR knockout screen | Gene essentiality and synthetic lethality | Identifying modifiers of saccharopine pathway |
| RNA-seq | Transcriptome changes | Assessing global effects of enzyme loss |
| Proteomics | Protein expression and modifications | Detecting compensatory pathways |
| Metabolomics | Levels of saccharopine, lysine, glutamate | Diagnosing metabolic disorders |
| Western blot | Protein expression and tagging | Validating knockout or knock-in models |
| Immunofluorescence | Subcellular localization | Determining mitochondrial vs cytosolic localization |
Enzymatic Activity Assays
Saccharopine dehydrogenase activity can be measured spectrophotometrically by monitoring the reduction of NAD+ to NADH at 340 nm, using saccharopine as substrate. This method is widely used to quantify enzyme kinetics and inhibition.
CRISPR-Cas9 Knockout Screening
CRISPR knockout screens can identify genes that modulate saccharopine dehydrogenase activity or compensate for its loss. Libraries targeting metabolic enzymes can be used to uncover synthetic lethal interactions.
RNA-Seq and Proteomics
Transcriptomic and proteomic profiling of cells with altered saccharopine dehydrogenase activity can reveal downstream metabolic and signaling changes. This is useful for understanding the broader impact of the enzyme on cellular pathways.
Metabolite Profiling
Mass spectrometry-based metabolomics can quantify saccharopine, lysine, glutamate, and other pathway intermediates in cells or tissues with modified enzyme activity.
How CRISPR Can Be Used to Study GO:0004753 saccharopine dehydrogenase activity
Knockout
CRISPR-Cas9 knockout of AASS or other genes encoding saccharopine dehydrogenase activity can create cell models to study lysine catabolism and disease mechanisms. These models are useful for assessing metabolic flux and identifying compensatory pathways.
Point Mutation
Introducing point mutations in the active site of saccharopine dehydrogenase, such as altering cysteine residues involved in thiol oxidation, can dissect the catalytic mechanism and regulation by redox state.
Knock-in
Knock-in of wild-type or mutant AASS with a tag (e.g., GFP) allows for tracking enzyme localization and activity in live cells. This is valuable for studying domain interactions and subcellular dynamics.
Overexpression
Overexpression of saccharopine dehydrogenase or the bifunctional enzyme in cell lines can enhance lysine catabolism and produce metabolic changes that mimic certain disease states or reveal regulatory mechanisms.
How EDITGENE Supports saccharopine dehydrogenase activity Research
Researchers studying saccharopine dehydrogenase activity-related genes often need to determine whether a candidate gene is causally involved in lysine metabolism, disease progression, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for saccharopine dehydrogenase activity research.
Frequently Asked Questions About saccharopine dehydrogenase activity
What is saccharopine dehydrogenase activity?
Saccharopine dehydrogenase activity (GO:0004753) is a molecular function that catalyzes the cleavage of saccharopine to release lysine or glutamate while reducing an electron acceptor such as NAD+.
What genes are involved in saccharopine dehydrogenase activity?
Key genes include AASS in mammals, which encodes a bifunctional enzyme with both lysine-ketoglutarate reductase and saccharopine dehydrogenase activities, and LKR/SDH in Arabidopsis.
What is the saccharopine pathway?
The saccharopine pathway is the major route for lysine catabolism in mammals and plants, involving lysine-ketoglutarate reductase and saccharopine dehydrogenase.
How is saccharopine dehydrogenase activity regulated?
It is regulated by domain interactions in bifunctional enzymes, redox state of active site thiols, and pH.
What diseases are associated with saccharopine dehydrogenase activity?
Deficiencies are linked to hyperlysinemia, L-2-hydroxyglutaric aciduria, and other saccharopine pathway-related diseases.
What is the difference between monofunctional and bifunctional saccharopine dehydrogenase?
Monofunctional saccharopine dehydrogenase only catalyzes the dehydrogenase step, while bifunctional enzymes also contain lysine-ketoglutarate reductase activity on the same polypeptide.
How can I study saccharopine dehydrogenase activity in the lab?
Common methods include spectrophotometric enzyme assays, CRISPR knockout models, metabolomics, and RNA-seq.
What is the role of saccharopine dehydrogenase in plants?
In plants, it is part of the bifunctional LKR/SDH enzyme that regulates lysine catabolism and seed development.
Can saccharopine dehydrogenase be a therapeutic target?
Yes, lysine alpha-ketoglutarate reductase, a related activity, is being explored as a therapeutic target for saccharopine pathway-related diseases.
What model organisms are used to study saccharopine dehydrogenase?
Mouse models, Arabidopsis thaliana, and human cell lines are commonly used.
Conclusion
Saccharopine dehydrogenase activity (GO:0004753) is a central enzymatic function in lysine catabolism, with critical roles in metabolism, development, and disease. Its regulation by domain interactions, redox state, and pH underscores its complexity and importance in cellular physiology. Dysregulation of this activity is linked to neurometabolic disorders such as L-2-hydroxyglutaric aciduria and hyperlysinemia, making it a potential therapeutic target. Continued research using CRISPR models and advanced omics will further elucidate its mechanisms and pave the way for novel interventions.
References
- 1. Rzem R et al.. 2015. A mouse model of L-2-hydroxyglutaric aciduria, a disorder of metabolite repair.. PLoS One 10(3):e0119540 PMID: 25763823
- 2. Zhu X et al.. 2002. The activity of the Arabidopsis bifunctional lysine-ketoglutarate reductase/saccharopine dehydrogenase enzyme of lysine catabolism is regulated by functional interaction between its two enzyme domains.. J Biol Chem 277(51):49655-61 PMID: 12393892
- 3. Bobyk KD et al.. 2011. The oxidation state of active site thiols determines activity of saccharopine dehydrogenase at low pH.. Arch Biochem Biophys 513(2):71-80 PMID: 21798231
- 4. Papes F et al.. 1999. Lysine degradation through the saccharopine pathway in mammals: involvement of both bifunctional and monofunctional lysine-degrading enzymes in mouse.. Biochem J 344 Pt 2(Pt 2):555-63 PMID: 10567240
- 5. Valderrama GV et al.. 2025. Lysine α-ketoglutarate reductase as a therapeutic target for saccharopine pathway related diseases.. Front Mol Neurosci 18:1695490 PMID: 41194801
- 6. Zhu X et al.. 2000. The catabolic function of the alpha-aminoadipic acid pathway in plants is associated with unidirectional activity of lysine-oxoglutarate reductase, but not saccharopine dehydrogenase.. Biochem J 351(Pt 1):215-20 PMID: 10998364
- 7. Azevedo RA et al.. 2001. Lysine metabolism in higher plants.. Amino Acids 20(3):261-79 PMID: 11354603
- 8. Tang G et al.. 1997. Regulation of lysine catabolism through lysine-ketoglutarate reductase and saccharopine dehydrogenase in Arabidopsis.. Plant Cell 9(8):1305-16 PMID: 9286108
